ST Segment Elevation Myocardial Infarction Clinical Trial
Official title:
Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction
Functional assessment of non-culprit lesions during percutaneous coronary intervention (PCI) in patients with acute coronary syndrome could improve risk stratification and shorten the duration of hospital stay by decreasing the need for additional non-invasive stress testing to detect residual myocardial ischemia. The investigators aimed to assess the reliability of the instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) measurements in non-culprit coronary lesions during the acute and subacute phase of ST-segment elevation myocardial infarction (STEMI).
BACKGROUND: Approximately 30% of patients who present with ST elevation myocardial
infarction have multivessel coronary artery disease on angiography. Whether percutaneous
coronary intervention (PCI) should be limited to the culprit lesion only or applied to all
angiographically critical non-culprit lesions is still debatable. The FAME 2 study has shown
that Fractional Flow Reserve (FFR)-guided PCI, with adenosine infusion, reduces the MACE
compared to medical therapy alone. In fact, according to the recent ESC clinical guidelines,
FFR guided PCI is in class I, evidence level A. Previous studies, have confirmed that FFR
values of non-culprit coronary lesions in STEMI patients provided similar values in the
acute phase compared to the subacute phase, 5-7 days after primary PCI. Consequently, it is
possible to assess angiographically borderline non-culprit lesions during the acute phase
and hence risk stratify STEMI patients, thus reducing the duration of hospital stay by
decreasing the need for additional non-invasive stress testing to detect residual myocardial
ischemia. However, the assessment of angiographically borderline lesions using FFR has its
own limitations related to the use of adenosine, which increases the risk of
bradyarrhythmias and high degree atrioventricular block, especially in the acute phase. This
would make functional assessment of the non-culprit lesions not always possible during the
acute phase.
Recently, a new functional algorithm, called "instantaneous wave-free ratio" (iFR) has been
introduced. Similar to FFR, it gives a functional assessment of coronary lesions by
measuring the trans-stenotic gradient during ventricular diastole, where intramyocardial
resistance is minimal and constant. This phase has been shown to be comparable to the
maximum hyperemic state of FFR assessment.
The measurement of iFR during the acute phase of STEMI has not yet been evaluated.
AIM: The aim of this study is to assess the reliability of the instantaneous wave-free ratio
(iFR) and fractional flow reserve (FFR) measurements in non-culprit coronary lesions during
the acute and subacute phase of ST-segment elevation myocardial infarction (STEMI).
METHOD: Patients undergoing primary PCI for STEMI and presenting with multivessel coronary
disease (at least one ≥ 50% diameter stenosis in a non-infarct-related coronary artery) were
enrolled in a prospective observational registry. Coronary lesions were evaluated with both
iFR and FFR immediately after primary PCI (acute phase) and 7 ± 3 days later (subacute
phase).
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03895983 -
ST Segment Resolution After Primary Percutaneous Coronary Intervention.
|
||
Not yet recruiting |
NCT03252665 -
Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
|
Phase 4 | |
Completed |
NCT02026219 -
Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction
|
Phase 4 | |
Completed |
NCT03247738 -
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
|
Phase 4 | |
Recruiting |
NCT05461781 -
Distal Transradial Access for Primary PCI in STEMI Patients to Prevent RAO
|
N/A | |
Recruiting |
NCT03561389 -
iFR-guided Revascularization in STEMI
|
||
Completed |
NCT01538303 -
Microvascular Dysfunction in Acute Myocardial Infarction (AMI) and Its Relation to Outcome
|
||
Recruiting |
NCT02979236 -
Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI
|
N/A | |
Completed |
NCT05705089 -
Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
|
Phase 3 | |
Completed |
NCT01897350 -
Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial
|
N/A | |
Not yet recruiting |
NCT03753269 -
Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction
|
Phase 4 | |
Completed |
NCT03234348 -
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT03406832 -
Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
|
N/A | |
Recruiting |
NCT03406819 -
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
|
N/A | |
Recruiting |
NCT03508232 -
Doxycycline to Protect Heart Muscle After Heart Attacks
|
Phase 2 | |
Recruiting |
NCT04220736 -
Early Prediction of QFR in STEMI-Pharmaco-invasice
|
||
Completed |
NCT03780335 -
Early Prediction of QFR in STEMI-I
|
||
Recruiting |
NCT03787745 -
Ischemic Postconditioning in STEMI Patients Treated With Primary PCI
|
N/A | |
Recruiting |
NCT03621111 -
A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction
|
N/A | |
Recruiting |
NCT03764241 -
Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
|
Phase 3 |